NCKAP1 and clear cell renal carcinoma: NCKAP1 was found to inhibit the malignant behavior of renal clear cell carcinoma cells in studies of renal clear cell carcinoma, suggesting its potential as a prognostic biomarker for screening patients in clinical practice.